loader
Please Wait
Applying Filters...
Close
4

Athena Athena

X

List of all Manufacturers, Suppliers & Exporters of Upadacitinib API listed on PharmaCompass with details of regulatory filings

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 Shandong Chenghui Shuangda Pharmaceutical (1)

02 Transo-Pharm USA LLC (1)

03 Metrochem API Private Limited (1)

04 Shandong Loncom Pharmaceutical (1)

05 Sigmak Lifesciences (1)

06 Shandong Boyuan Pharmaceutical (1)

07 Jinan Tantu Chemicals (1)

08 Egis Pharmaceuticals PLC (1)

09 Aurobindo Pharma Limited (1)

10 Beijing Hope Pharmaceutical (1)

11 Beijing Sjar Technology Development (1)

12 Changzhou Pharmaceutical Factory (1)

13 Chiral Quest (2)

14 Crystal Pharmaceutical (1)

15 Curia (1)

16 Hetero Drugs (1)

17 Lee Pharma (1)

18 MSN Laboratories (1)

19 Mankind Pharma (1)

20 Morepen Laboratories (1)

21 Optimus Pharma (1)

22 Suzhou Biosyntech (1)

23 Teva API (1)

24 Viatris (1)

25 Zhejiang Tianyu Pharmaceutical Co., Ltd (1)

26 Blank (1)

filter

01 China (12)

02 Hungary (1)

03 India (9)

04 Israel (1)

05 U.S.A (3)

06 Blank (1)

filter

01 Active (8)

02 Blank (19)

filter

01 Blank (27)

filter

01 Blank (27)

filter

01 Blank (27)

See all info for this supplier

See Less

USDMF

Check Availability USDMF

CEP/COS

Check Availability CEP/COS

Japanese DMF

Check Availability JDMF

Written Confirmation

Check Availability WC

Application Number
Status
 
Filing Details
Issue/Submission Date
Transo Pharm USA Company Banner

Biotechgate Digital

Not Confirmed

envelop Contact Supplier
See all info for this supplier

See Less

USDMF

Close USDMF

CEP/COS

Close CEP/COS

Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
Status
 
Filing Details
Issue/Submission Date
Shandong Loncom Pharmaceutical company banner

Biotechgate Digital

Not Confirmed

envelop Contact Supplier
See all info for this supplier

See Less

USDMF

Close USDMF

CEP/COS

Close CEP/COS

Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
Status
 
Filing Details
Issue/Submission Date
Sigmak Lifesciences CB

Biotechgate Digital

Not Confirmed

envelop Contact Supplier
See all info for this supplier

See Less

USDMF

Close USDMF

CEP/COS

Close CEP/COS

Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
Status
 
Filing Details
Issue/Submission Date
Shandong Boyuan Pharmaceutical Company Banner

Biotechgate Digital

Not Confirmed

envelop Contact Supplier
URL Supplier Web Content
See all info for this supplier

See Less

USDMF

Found USDMF

CEP/COS

Close CEP/COS

Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
38427
Status
Active
Fees Unpaid
N/A
 
Filing Details
UPADACITINIB
Issue/Submission Date
2023-06-15
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
See all info for this supplier

See Less

USDMF

Found USDMF

CEP/COS

Close CEP/COS

Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
38153
Status
Active
Fees Paid
Reviewed
 
Filing Details
UPADACITINIB
Issue/Submission Date
2023-03-26
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
See all info for this supplier

See Less

USDMF

Found USDMF

CEP/COS

Close CEP/COS

Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
38095
Status
Active
Fees Paid
Reviewed
 
Filing Details
UPADACITINIB
Issue/Submission Date
2023-02-22
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
See all info for this supplier

See Less

USDMF

Found USDMF

CEP/COS

Close CEP/COS

Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
37853
Status
Active
Fees Unpaid
N/A
 
Filing Details
UPADACITINIB INTERMEDIATE 2 - (3R,4...
Issue/Submission Date
2023-02-20
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
See all info for this supplier

See Less

USDMF

Found USDMF

CEP/COS

Close CEP/COS

Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
37868
Status
Active
Fees Unpaid
N/A
 
Filing Details
UPADACITINIB INTERMEDIATE 1 - TERT-...
Issue/Submission Date
2023-02-20
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
See all info for this supplier

See Less

USDMF

Found USDMF

CEP/COS

Close CEP/COS

Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
37149
Status
Active
Fees Paid
Reviewed
 
Filing Details
UPADACITINIB
Issue/Submission Date
2022-06-01
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
See all info for this supplier

See Less

USDMF

Found USDMF

CEP/COS

Close CEP/COS

Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
38051
Status
Active
Fees Paid
N/A
 
Filing Details
UPADACITINIB HEMIHYDRATE
Issue/Submission Date
2023-02-09
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
See all info for this supplier

See Less

USDMF

Close USDMF

CEP/COS

Close CEP/COS

Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
Status
 
Filing Details
Issue/Submission Date
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
See all info for this supplier

See Less

USDMF

Close USDMF

CEP/COS

Close CEP/COS

Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
Status
 
Filing Details
Issue/Submission Date
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
See all info for this supplier

See Less

USDMF

Close USDMF

CEP/COS

Close CEP/COS

Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
Status
 
Filing Details
Issue/Submission Date
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
See all info for this supplier

See Less

USDMF

Close USDMF

CEP/COS

Close CEP/COS

Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
Status
 
Filing Details
Issue/Submission Date
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
See all info for this supplier

See Less

USDMF

Close USDMF

CEP/COS

Close CEP/COS

Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
Status
 
Filing Details
Issue/Submission Date
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
See all info for this supplier

See Less

USDMF

Close USDMF

CEP/COS

Close CEP/COS

Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
Status
 
Filing Details
Issue/Submission Date
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
See all info for this supplier

See Less

USDMF

Close USDMF

CEP/COS

Close CEP/COS

Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
Status
 
Filing Details
Issue/Submission Date
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
See all info for this supplier

See Less

USDMF

Close USDMF

CEP/COS

Close CEP/COS

Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
Status
 
Filing Details
Issue/Submission Date
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
See all info for this supplier

See Less

USDMF

Close USDMF

CEP/COS

Close CEP/COS

Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
Status
 
Filing Details
Issue/Submission Date
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
See all info for this supplier

See Less

USDMF

Close USDMF

CEP/COS

Close CEP/COS

Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
Status
 
Filing Details
Issue/Submission Date
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
See all info for this supplier

See Less

USDMF

Close USDMF

CEP/COS

Close CEP/COS

Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
Status
 
Filing Details
Issue/Submission Date
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Contact Supplier
Flag Country
Virtual Booth Virtual Booth
Digital Content Digital Content
URL Supplier Web Content
See all info for this supplier

See Less

USDMF

Found USDMF

CEP/COS

Close CEP/COS

Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
38344
Status
Active
Fees Unpaid
Reviewed
 
Filing Details
UPADACITINIB
Issue/Submission Date
2023-05-20
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for 1310726-60-3 / Upadacitinib API manufacturers, exporters & distributors?

Upadacitinib manufacturers, exporters & distributors 1

30

PharmaCompass offers a list of Upadacitinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Upadacitinib manufacturer or Upadacitinib supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Upadacitinib manufacturer or Upadacitinib supplier.

PharmaCompass also assists you with knowing the Upadacitinib API Price utilized in the formulation of products. Upadacitinib API Price is not always fixed or binding as the Upadacitinib Price is obtained through a variety of data sources. The Upadacitinib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Upadacitinib

Synonyms

1310726-60-3, Abt-494, Rinvoq, Upadacitinib anhydrous, 4ra0kn46e0, (3s,4r)-3-ethyl-4-(1,5,7,10-tetrazatricyclo[7.3.0.02,6]dodeca-2(6),3,7,9,11-pentaen-12-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide

Cas Number

1310726-60-3

Unique Ingredient Identifier (UNII)

4RA0KN46E0

About Upadacitinib

Upadacitinib is an oral Janus kinase (JAK)1-selective inhibitor and a disease-modifying antirheumatic drug (DMARD) used in the treatment of rheumatoid arthritis to slow down disease progression. Rheumatoid arthritis is a chronic autoimmune inflammatory disease affecting the peripheral joints. It is characterized by synovial inflammation and hyperplasia, autoantibody production, cartilage damage and bone destruction, leading to co-morbidities. Despite a variety of therapeutic agents available for treatment, up to 40% of the patients do not respond to current therapies, including biological therapies. The etiology of the disease is mostly unknown; however, the role of JAK as a driver of immune-mediated conditions was discovered, leading to the use of JAK as therapeutic targets for rheumatoid arthritis. To reduce dose-related toxicity (as seen with some pan-JAK inhibitors) without significantly affecting efficacy, more selective JAK1 inhibitors, upadacitinib and [filgotinib], were developed. The FDA approved Upadacitinib in August 2019 for the treatment of adults with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate. In December 2019, it was additionally approved by the European Commission for the same indication in patients with inadequate response or intolerance to one or more DMARDs and can be used as monotherapy or in combination with methotrexate. Upadacitinib is marketed under the brand name RINVOQ for oral administration. It is currently being investigated in several clinical trials assessing its therapeutic effectiveness in other inflammatory diseases, such as psoriatic arthritis, ankylosing spondylitis, ulcerative colitis, and atopic dermatitis.

Upadacitinib Manufacturers

A Upadacitinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Upadacitinib, including repackagers and relabelers. The FDA regulates Upadacitinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Upadacitinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Upadacitinib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Upadacitinib Suppliers

A Upadacitinib supplier is an individual or a company that provides Upadacitinib active pharmaceutical ingredient (API) or Upadacitinib finished formulations upon request. The Upadacitinib suppliers may include Upadacitinib API manufacturers, exporters, distributors and traders.

click here to find a list of Upadacitinib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Post Enquiry
POST ENQUIRY